Strategic Finance Manager, Vial

Salary not provided

+ Equity

Excel
Mid level
Remote in US
Vial

Contact research organization for biotech

Job no longer available

Vial

Contact research organization for biotech

101-200 employees

HealthcareB2BMedTech

Job no longer available

Salary not provided

+ Equity

Excel
Mid level
Remote in US

101-200 employees

HealthcareB2BMedTech

Company mission

To reimagine clinical trials and deliver faster and more efficient trials for sponsors.

Role

Who you are

  • 3+ years of experience in investment banking and private equity, and / or corporate finance
  • Experience leading deal processes, including managing key 3rd party intermediaries (e.g. consultants, accountants, tax advisors)
  • Strong excel and financial modeling skills

What the job involves

  • Work closely with senior leadership to support key strategic initiatives including fundraising, M&A, strategic partnerships, licensing, and capital allocation planning
  • Lead the corporate FP&A reporting process to support performance reviews and goal setting
  • Own the financial model and communicate forecasts to internal and external stakeholders
  • Assist in development of Board presentations and materials
  • Track investment activity and insights across the life sciences industry

Otta's take

Theo Margolius headshot

Theo Margolius

COO of Otta

Clinical trials can decide the financial success for a drug that takes decades to make, as without them the Food and Drug Administration cannot approve it. Vial organizes the trial process, offering three technology platforms for starting up sites, capturing data and recruiting patients.

The problem currently faced by the biotech industry is that clinical trials are slow-moving and capital-intensive. One inefficiency is the specificity required when cherry-picking the right candidates for a drug. Aiding this process, Vial helps companies find patients across any given country and better collect data that can be organized.

With impressive funding at its disposal, one round recently led by General Catalyst, Vial will continue to help simplify an unorganised industry. With investments in this field becoming increasingly active, Vial is well placed to continue its upwards growth.

Insights

Top investors

Few candidates hear
back within 2 weeks

10% employee growth in 12 months

Company

Funding (1 round)

Dec 2022

$67m

SERIES B

Total funding: $67m

Company benefits

  • Unlimited Vacation
  • Exceptional healthcare, dental, and vision coverage
  • Paid parental leave
  • Remote-first culture

Company values

  • Do it Right - Our goal is to build a generational company. We need to be ruthless about being excellent
  • Ship It - Move fast. We each operate autonomously within an OKR structure and ultimate vision of the company
  • Be Intellectually Honest - Be bold, but operate with integrity and transparency
  • Writing is a Superpower - The best decisions start with a well-framed argument in a document
  • ABCD (Always Be Connecting Dots) - Relationships are the main driver of performance, not tech
  • Structure It - We value structured, well developed thinking. Carefully laid out, deeply contemplated and well reasoned cases are incredibly valuable
  • Have Fun! - If something big happens, you can jump up and down and cheer!

Company HQ

SoMa, San Francisco, CA

Founders

Andrew Brackin

(Co-founder)

Previously served as CRO for Vial. Experience as Early Head of Growth for Newfront and as part of the Founding Team for Jobr for Business.

Simon Burns

(CEO & co-founder)

Previously acted as Senior Product Manager for Chime and as Product Manager for Opendoor. Co-founded Wealthcoin.

Share this job